**Association Between HLA Gene Polymorphism And The Genetic Susceptibility Of HIV Infection**

Fang Yuan and Yongzhi Xi

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/57538

### **1. Introduction**

[207] Aida K, Juarez S, Kikuchi M, et al. HLA-B35 and MICA-A5 synergistically enhanced

[208] Lima-Junior JC, Rodrigues-da-Silva RN, Banic DM, Jiang J, Singh B, Fabrício-Silva GM, Porto LC, Meyer EV, Moreno A, Rodrigues MM, Barnwell JW, Galinski MR, de Oliveira-Ferreira J. Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian en‐ demic area. PLoS One. 2012;7(5). http://www.ncbi.nlm.nih.gov/pmc/articles/

[209] Lulli P, Mangano VD, Onori A, Batini C, Luoni G, Sirima BS, Nebie I, Chessa L, Pet‐ rarca V, Modiano D. HLA-DRB1 and -DQB1 loci in three west African ethnic groups: genetic relationship with sub-Saharan African and European populations. Hum Im‐ munol. 2009 Nov;70:903-9. http://www.sciencedirect.com/science/article/pii/

[210] Osafo-Addo AD, Koram KA, Oduro AR, Wilson M, Hodgson A, Rogers WO. HLA-DRB1\*04 allele is associated with severe malaria in northern Ghana. Am J Trop Med Hyg. 2008 Feb;78:251-5. http://www.ajtmh.org/content/78/2/251.long (accessed 03

[211] Hananantachai H, Patarapotikul J, Ohashi J, Naka I, Looareesuwan S, Tokunaga K.Polymorphisms of the HLA-B and HLA-DRB1 genes in Thai malaria patients. Jpn J Infect Dis. 2005 Feb;58:25-8. http://www0.nih.go.jp/JJID/58/25.html (accessed 04 Sep‐

[212] Shankarkumar U, Devaraj JP, Ghosh K, Karnad D, Anand K, Mohanty D. HLA asso‐ ciations in P. falciparum malaria patients from Mumbai, western India. Indian J Ma‐

susceptibility to Chagas Heart disease. MHC 2000;7:63-70.

PMC3359319/ (accessed 30 September 2013).

S0198885909002006 (accessed 03 October 2013).

September 2013).

300 HLA and Associated Important Diseases

tember 2013).

lariol. 2002 Sep-Dec; 39:76-82.

Human leukocyte antigen (HLA) complex, which refers to a group of closely linked genes on the short arm of the sixth human chromosome, is considered the most polymorphic genetic marker that has so far been reported in the human. HLA plays a significant role in the immune response, particularly in antiviral immunity. Although HLA and genetic predisposition to various autoimmune diseases have been separately studied for the past 40 years, the evaluation of the correlation between the two was initiated only within the last 10 years. In recent years, research on HLA polymorphisms and susceptibility to various infectious diseases has attracted significant attention owing to the critical role of HLA in diseases such as SARS and hepatitis B. In particular, HLA polymorphism, HIV, and genetic predisposition to AIDS have emerged as research areas of immense clinical significance.

Human immunodeficiency virus (HIV) infection is able to perturb and alter gene expression through several mechanisms that can, lastly, cause acquired immunodeficiency syndrome (AIDS) Figure 1. Meanwhile, associations between disease parameters and the genetic makeup of the host and virus may be crucial in determining the outcome of HIV-1 infection.

According to Joint United Nations Programme on HIV/AIDS, there were approximately 40 million HIV-infected people worldwide at the end of 2004. Limiting the susceptibility to HIV, predicting the course of AIDS, and reversing it are some of the challenging tasks that need to be addressed urgently. Existing data demonstrates that the susceptibility to HIV differs among individuals, and significant differences exist in the disease progression in HIV-infected persons. In general, it takes less than 10 years from the time of HIV infection to the manifes‐ tation of typical AIDS symptoms. However, a small subset of HIV-infected people (0.8%) are

© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

and HLA-B\*35 in ethnic groups of Han. However, findings of research on Caucasian individuals did not agree with this notion. HLA-B\*07, found among people of African descent, is considered to correlate with the susceptibility to HIV, but the similar correlation has not been reported among people of other ethnic groups. Research on other ethnic groups indicates that HLA-B\*18 and the HLA-A2 either influence HIV-1 infectivity or act as protective genes that inhibit the incidence of AIDS. The homozygous HLA-G 14-bp nsertion/deletion genotype is associated with higher viral load, lower CD4 cell count, and

Association Between HLA Gene Polymorphism And The Genetic Susceptibility Of HIV Infection

http://dx.doi.org/10.5772/57538

303

Considering the limitation of the small population evaluated, polymorphisms outside the peptide binding region of the HLA class I molecule can play a key role in HIV progression through interaction with other immune-relevant receptors. Some results identify co-operative effects between HLA Class I alleles in the control of HIV-1 in an extended Southern African cohort, and underline complementarity and breadth of the CD8+ T cell targeting as one potential mechanism for this effect. HLA-A-restricted Gag-specific responses can impose selection pressure on HIV. Vaidya et al analyzed the associations between HLA-B alleles and HIV-1 viral replication during acute infection and VLSP in untreated subjects. The results show that the effect of HLA-B\*57 on viral control is more pronounced during the later stages of primary HIV-1 infection, while HLA-B\*97 is more broadly associated with HIV-1 viral load during primary infection. In HIC (HIV controllers, a unique group of infected individuals who are able to control HIV naturally), HLA-B\*57 and the amount of ultrasensitive viral load seem to play a role in the HIV-specific CD8+ T cell responses. Some results provide support for the role of HLA-B\*51-restricted CTLs and functional avidity in the control of early HIV-1 infection. HALS (HIV/Highly active antiretroviral therapy-associated lipodystrophy syndrome) is associated with combined low-expression TS (thymidylate synthase) and MTHFR (methylenetetrahydrofolate reductase) associated with high activity polymorphisms but not with HLA-B\*40:01 carriage in Caucasian patients with long-term exposure to stavudine. For details, see

Richard et al characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. They found that HIV peptides presented by higher expressed HLA-C alleles were more likely to elicit CTL responses than peptides presented by low expression HLA-C allotypes, such that higher HLA-C expression was correlated with increased likelihood of cytotoxic T lymphocyte responses and frequency of viral escape mutation. It is also pointed out that HLA-C and HLA-E collaborate to keep the HIV-1 virus at bay. HLA-C can present antigens to CTL, and it is able to inhibit NK cell lysis, but for some reason it is normally expressed on the cell surface at levels approximately 10-fold less than most HLA-A and HLA-B allotypes. The mechanisms that regulate HLA-C expression and the link between this molecule and HIV infection are not yet completely understood. Maybe a new miRNA targeting sequences identified on HLA-C gene and the low level of affinity between *β*2M and the HLA-

C heavy chains can explain for this low level of expression.

increased mortality compared with HLA-G 14-bp carriers.

Table 1.

**Figure 1.** HIV virus is formed by a diploid single strand RNA genome enclosed in a truncated cone capsid with a phos‐ pholipidic bilayer envelope, containing the proteins that allow the virus entry into the cells. The HIV-1 infection is mediated by interaction between the proteins of the viral envelope, leukocyte receptor, and coreceptor. This interac‐ tion causes the membranes fusion and the uncoating of the virion core. The viral RNA is reverse transcribed in DNA which enters in the nucleus where the integrase enzyme catalyzes the insertion of the viral genome into the genome of the host cell. The expression of integrated viral genome is controlled by the RNA-binding proteins tat and rev. A set of RNAs are transported from the nucleus to the cytoplasm, where they can be translated or packaged. The new core proteins localize near the cell membrane, while the envelope mRNA is translated at the endoplasmic reticulum (ER) and subsequently the envelope proteins are placed on the cell membrane. Finally, the capsid proteins are assembled with the viral genomic RNA, and an immature virion begins to bud from cell surface.

asymptomatic for over 10 years. According to a number of studies, the HLA complex is considered as the most noteworthy genetic marker that is closely related to AIDS progression and highlights the differences in genetic susceptibility of HIV-infected individuals.

### **2. HLA polymorphism and genetic predisposition to HIV**

**1.** Epidemiological survey: Worldwide epidemiological surveys indicate that there is a close relationship between HIV/AIDS and HLA. Although global research reports at different times have demonstrated the involvement of HLA in the differential susceptibility to HIV, the individual HLA locus has not been validated to correlate with HIV infection or AIDS progression. For example, some reports indicate a correlation between HIV susceptibility and HLA-B\*35 in ethnic groups of Han. However, findings of research on Caucasian individuals did not agree with this notion. HLA-B\*07, found among people of African descent, is considered to correlate with the susceptibility to HIV, but the similar correlation has not been reported among people of other ethnic groups. Research on other ethnic groups indicates that HLA-B\*18 and the HLA-A2 either influence HIV-1 infectivity or act as protective genes that inhibit the incidence of AIDS. The homozygous HLA-G 14-bp nsertion/deletion genotype is associated with higher viral load, lower CD4 cell count, and increased mortality compared with HLA-G 14-bp carriers.

Considering the limitation of the small population evaluated, polymorphisms outside the peptide binding region of the HLA class I molecule can play a key role in HIV progression through interaction with other immune-relevant receptors. Some results identify co-operative effects between HLA Class I alleles in the control of HIV-1 in an extended Southern African cohort, and underline complementarity and breadth of the CD8+ T cell targeting as one potential mechanism for this effect. HLA-A-restricted Gag-specific responses can impose selection pressure on HIV. Vaidya et al analyzed the associations between HLA-B alleles and HIV-1 viral replication during acute infection and VLSP in untreated subjects. The results show that the effect of HLA-B\*57 on viral control is more pronounced during the later stages of primary HIV-1 infection, while HLA-B\*97 is more broadly associated with HIV-1 viral load during primary infection. In HIC (HIV controllers, a unique group of infected individuals who are able to control HIV naturally), HLA-B\*57 and the amount of ultrasensitive viral load seem to play a role in the HIV-specific CD8+ T cell responses. Some results provide support for the role of HLA-B\*51-restricted CTLs and functional avidity in the control of early HIV-1 infection. HALS (HIV/Highly active antiretroviral therapy-associated lipodystrophy syndrome) is associated with combined low-expression TS (thymidylate synthase) and MTHFR (methylenetetrahydrofolate reductase) associated with high activity polymorphisms but not with HLA-B\*40:01 carriage in Caucasian patients with long-term exposure to stavudine. For details, see Table 1.

Richard et al characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. They found that HIV peptides presented by higher expressed HLA-C alleles were more likely to elicit CTL responses than peptides presented by low expression HLA-C allotypes, such that higher HLA-C expression was correlated with increased likelihood of cytotoxic T lymphocyte responses and frequency of viral escape mutation. It is also pointed out that HLA-C and HLA-E collaborate to keep the HIV-1 virus at bay. HLA-C can present antigens to CTL, and it is able to inhibit NK cell lysis, but for some reason it is normally expressed on the cell surface at levels approximately 10-fold less than most HLA-A and HLA-B allotypes. The mechanisms that regulate HLA-C expression and the link between this molecule and HIV infection are not yet completely understood. Maybe a new miRNA targeting sequences identified on HLA-C gene and the low level of affinity between *β*2M and the HLA-C heavy chains can explain for this low level of expression.

asymptomatic for over 10 years. According to a number of studies, the HLA complex is considered as the most noteworthy genetic marker that is closely related to AIDS progression

**Figure 1.** HIV virus is formed by a diploid single strand RNA genome enclosed in a truncated cone capsid with a phos‐ pholipidic bilayer envelope, containing the proteins that allow the virus entry into the cells. The HIV-1 infection is mediated by interaction between the proteins of the viral envelope, leukocyte receptor, and coreceptor. This interac‐ tion causes the membranes fusion and the uncoating of the virion core. The viral RNA is reverse transcribed in DNA which enters in the nucleus where the integrase enzyme catalyzes the insertion of the viral genome into the genome of the host cell. The expression of integrated viral genome is controlled by the RNA-binding proteins tat and rev. A set of RNAs are transported from the nucleus to the cytoplasm, where they can be translated or packaged. The new core proteins localize near the cell membrane, while the envelope mRNA is translated at the endoplasmic reticulum (ER) and subsequently the envelope proteins are placed on the cell membrane. Finally, the capsid proteins are assembled

**1.** Epidemiological survey: Worldwide epidemiological surveys indicate that there is a close relationship between HIV/AIDS and HLA. Although global research reports at different times have demonstrated the involvement of HLA in the differential susceptibility to HIV, the individual HLA locus has not been validated to correlate with HIV infection or AIDS progression. For example, some reports indicate a correlation between HIV susceptibility

and highlights the differences in genetic susceptibility of HIV-infected individuals.

**2. HLA polymorphism and genetic predisposition to HIV**

with the viral genomic RNA, and an immature virion begins to bud from cell surface.

302 HLA and Associated Important Diseases


Jabri and his colleagues used two strains of HIV-1 and HIV-2 to infect peripheral blood cells with different HLA antigenic specificities, and reported that no single HLA antigen was capable of preventing both types of HIV infection. For example, HLA-B52 showed suscepti‐ bility to HIV-1 viral strains, whereas it was not susceptible to HIV-2 viral strains. HLA-B58 showed susceptibility to HIV-2 viral strains, but it was not susceptible to HIV-1 viral strains. HLA-B44 influenced the immune function only against certain HIV-1/2 strains. It is still therefore still ambiguous whether different HLA phenotypes influence the susceptibility to and *in vivo* effects of HIV infection, which needs to be verified by experiments with larger

Association Between HLA Gene Polymorphism And The Genetic Susceptibility Of HIV Infection

http://dx.doi.org/10.5772/57538

305

HLA-G variant expression has a considerable impact on the control of HIV replication, an effect that seems to be mediated primarily by the protein specificity of CD4(+) T cell responses to HIV Gag and Nef. Numerous studies have been conducted, aimed at observing the expression of the molecule HLA-G in the early stage of infection by HIV and its progression. In 2004, Derrien and colleagues demonstrated that during HIV-1 infection the HLA-G1 isoform was down regulated by a Vpu dependent mechanism, which recognizes a double lysine residues in 4 and 5 positions of the C terminus. The HLA-G1 isoform has the major ability to present viral peptides to CD8+ T lymphocytes; therefore, the recognition of HIV-1 infected cells by CD8+ T lymphocytes could depend on the expression of HLA-G1.More results show that HLA-G Treg plays an important role for balancing by stander immune activation and anti-viral immune activity in HIV-1 infection and suggest that the loss of these cells during advanced HIV-1 infection may contribute to immune dysregulation and HIV-1 disease progression. The connection between miRNA, HLA-G expression, and HIV-1 also needs to be further explored

because it can reveal novel information about HIV-1 control of the immune system.

**3.** Statistical analysis of the correlation between HLA gene polymorphism and HIV infection or AIDS susceptibility: Previously published research findings have been analyzed to evaluate the diversity in the correlation of HLA with HIV/AIDS susceptibility. Metaanalysis was anticipated to identify the common features. Research articles that satisfy the selection criteria were retrieved and the original data in the documents were processed and analyzed, wherein B35, B62, DR5, and DR11 were identified as genes that facilitate HIV-1 susceptibility and/or occurrence of AIDS, while A10, B18, B27, B5, and DR1 were identified as protective genes against HIV-1 infection and/or occurrence of AIDS. Since meta-analysis is an observational study, variations are likely to be introduced in each step of the analysis, and the results need to be validated by testing in laboratories with a large

**3. Possible mechanisms that HLA influence HIV infection susceptibility or**

**1.** Infection receptors: HIV combines with the CD4 molecule and other coreceptors to invade T cells during infection. HIV susceptibility is affected when the above-mentioned receptors have natural defects or mutations. So far, it has been verified that receptors of

sample sizes.

sample size.

**AIDS progression**

**Table 1.** HLA genes, haplotype, and supertype related to HIV-1 susceptibility and AIDS progression

**2.** *In vitro* study on HLA and HIV infection susceptibility: It is difficult to extrapolate the common characteristics from the results of epidemiological surveys owing to the abun‐ dance of inherent variation. Some researchers try to analyze HLA and HIV infection susceptibility by using *in vitro* approaches, and speculate the relationship between HLA polymorphism and HIV infection susceptibility or AIDS progression. *In vitro* studies can better control significant influencing factors such as the type, developmental stage and culturing conditions of cells, type of HIV strain, density of infection, and mechanisms, as well as minimize the variable factors that will have an effect on statistical findings. Second, *in vitro* experiments facilitate the consistent evaluation of critical factors as well as the application of uniform testing standards.

Jabri and his colleagues used two strains of HIV-1 and HIV-2 to infect peripheral blood cells with different HLA antigenic specificities, and reported that no single HLA antigen was capable of preventing both types of HIV infection. For example, HLA-B52 showed suscepti‐ bility to HIV-1 viral strains, whereas it was not susceptible to HIV-2 viral strains. HLA-B58 showed susceptibility to HIV-2 viral strains, but it was not susceptible to HIV-1 viral strains. HLA-B44 influenced the immune function only against certain HIV-1/2 strains. It is still therefore still ambiguous whether different HLA phenotypes influence the susceptibility to and *in vivo* effects of HIV infection, which needs to be verified by experiments with larger sample sizes.

**Cohorts used in study**

304 HLA and Associated Important Diseases

Male Caucasian Homosexuals

**HLA locus or haplotype or supertype**

Yi Ethnicity B\*07, B\*35, B\*46 B\*55, B\*44, B\*78

Kenya A\*2301 A2/6802 supertype(LT)

Kenya A\*29, Cw\*07, Cw\*08 (HT) B\*18(LT)

Argentina A\*24, B\*18, B\*39 B\*44, B\*55 African-American DQB1\*0201 DQB1\*0303 Caucasian DQB1\*0603, DRB1\*04 DQB1\*0303

European A\*29, B\*22, DR\*11(FP) B\*14, Cw\*08(SP)

European-American HLA-C low expression HLA-C high expression

**Table 1.** HLA genes, haplotype, and supertype related to HIV-1 susceptibility and AIDS progression

B\*35 A2 supertype

**2.** *In vitro* study on HLA and HIV infection susceptibility: It is difficult to extrapolate the common characteristics from the results of epidemiological surveys owing to the abun‐ dance of inherent variation. Some researchers try to analyze HLA and HIV infection susceptibility by using *in vitro* approaches, and speculate the relationship between HLA polymorphism and HIV infection susceptibility or AIDS progression. *In vitro* studies can better control significant influencing factors such as the type, developmental stage and culturing conditions of cells, type of HIV strain, density of infection, and mechanisms, as well as minimize the variable factors that will have an effect on statistical findings. Second, *in vitro* experiments facilitate the consistent evaluation of critical factors as well as the

Caucasian Heterozygous HLA locus, Type I B\*35, Cw\*04

American - B\*18(LT)

FP, fast progression; SP, slow progression; HT, high transmission; LT, low transmission

American B\*54, B\*55, B\*56 -

Zimbabwean HLA-G 14-bp insertion/deletion

application of uniform testing standards.

Zambian A\*02-Cw\*16, A\*23-B\*14, A\*23-Cw\*07(FP) B\*57, B\*39, A\*30-Cw\*03(SP)

Han Ethnicity B\*35 -

European A1-Cw7-B8-DR3, A24(FP) -

**Susceptible to HIV or AIDS FP Non-susceptible to HIV or AIDS SP**

HLA-G variant expression has a considerable impact on the control of HIV replication, an effect that seems to be mediated primarily by the protein specificity of CD4(+) T cell responses to HIV Gag and Nef. Numerous studies have been conducted, aimed at observing the expression of the molecule HLA-G in the early stage of infection by HIV and its progression. In 2004, Derrien and colleagues demonstrated that during HIV-1 infection the HLA-G1 isoform was down regulated by a Vpu dependent mechanism, which recognizes a double lysine residues in 4 and 5 positions of the C terminus. The HLA-G1 isoform has the major ability to present viral peptides to CD8+ T lymphocytes; therefore, the recognition of HIV-1 infected cells by CD8+ T lymphocytes could depend on the expression of HLA-G1.More results show that HLA-G Treg plays an important role for balancing by stander immune activation and anti-viral immune activity in HIV-1 infection and suggest that the loss of these cells during advanced HIV-1 infection may contribute to immune dysregulation and HIV-1 disease progression. The connection between miRNA, HLA-G expression, and HIV-1 also needs to be further explored because it can reveal novel information about HIV-1 control of the immune system.

**3.** Statistical analysis of the correlation between HLA gene polymorphism and HIV infection or AIDS susceptibility: Previously published research findings have been analyzed to evaluate the diversity in the correlation of HLA with HIV/AIDS susceptibility. Metaanalysis was anticipated to identify the common features. Research articles that satisfy the selection criteria were retrieved and the original data in the documents were processed and analyzed, wherein B35, B62, DR5, and DR11 were identified as genes that facilitate HIV-1 susceptibility and/or occurrence of AIDS, while A10, B18, B27, B5, and DR1 were identified as protective genes against HIV-1 infection and/or occurrence of AIDS. Since meta-analysis is an observational study, variations are likely to be introduced in each step of the analysis, and the results need to be validated by testing in laboratories with a large sample size.

### **3. Possible mechanisms that HLA influence HIV infection susceptibility or AIDS progression**

**1.** Infection receptors: HIV combines with the CD4 molecule and other coreceptors to invade T cells during infection. HIV susceptibility is affected when the above-mentioned receptors have natural defects or mutations. So far, it has been verified that receptors of chemotactic factors (CCR35 and CXCR4) are coreceptors for HIV-1. When HIV-1 infects target cells, the viruses that combine with CD4 molecules combine with coreceptors in order to enter the target cells. In high-risk populations with close contact to infected individuals but no infection, approximately one-third of the CCR5 alleles undergo deletion mutation; for instance, deletion of 32 bases of CCR5 genes (referred to as CCR5Δ32 mutation), which results in a natural immunity of the organism against HIV-1 infection at the gene level. The mutation and polymorphism changes of alleles not only influence the ability of HIV-1 to infect the target cells, but also change the onset and progression of AIDS. It is possible that HLA participates in HIV invading process through similar means, and affects AIDS progression. However, there are no validated reports on HLA's direct participation in HIV-1 infection by acting as the receptor, so far. Therefore, the susceptibility theory, which suggests that HLA acts as a receptor, needs to be subjected to further scientific scrutiny.

**2.** HLA molecules selection pressure: The antigen-binding groove of HLA molecules combine with a specific epitope of the HIV protein (For example, gap 120), inducing the generation of helper T cells and cytotoxic T cells. In particular, CD8+ cytotoxic T lympho‐ cytes can kill infected CD4+ T lymphocyte in a direct manner, which can influence virus replication, transmission, and AIDS progression. HLA molecules can employ different epitopes for the same molecule, and stimulate generation of CTLs featuring different quantities as well as specific properties, which has been confirmed in previous studies. Therefore, this can better explain the differences in AIDS progress when individuals with certain HLA phenotypes infected with HIV.

During viral infection, some viruses undergo degradation by cellular proteasome complex, and the cytosolic antigenic peptides are carried into the ER. In this organelle, the peptides are captured by HLA I molecules and then exposed on the cell surface, triggering the cytotoxic activity of the circulating CD8+ T lymphocytes, as described previously. The HIV has devised different ways to evade the immune response including a Nef-dependent mechanism that downregulates the HLA I expression, thus avoiding the recognition of the infected cells by CD8+ T lymphocytes (Fig2). Selectively, Nef alters the expression of HLA-A and -B by recognition of a sequence (Y320SQAASS) present on the cytoplasmic tail of these HLA molecules accelerating their endocytosis from the plasma membrane and blocking the transport of newly synthesized MHC class I molecules to the cell surface. Nef maintains the expression of HLA-C -G and -E unchanged, in order to inhibit the innate response of the natural killer cells (NK). Furthermore, the gp41 protein of the viral envelope upregulates the synthesis of IL-10 by monocytes; in turn, as mentioned before, this cytokine increases the expression of HLA-G molecules to control immune response and facilitate infection.

and overcome the immune responses, resulting in HIV susceptibility of specific HLA types as well as a rapid progression of AIDS. Children of mothers with AIDS who have similar HLA genes are at a higher risk of being infected with HIV, and they tend to progress to AIDS in a shorter time. The possible reason for this is that the HIV of the mother might have adapted to the HLA environment in the host, and the virus replication increases when HLA similarity is high between the mother and child, which in turn makes it is easier for HIV to propagate and lead to a faster progression of AIDS. But sometimes specific mutation of HIV can also lead to a decrease in its virulence, enabling a reduced susceptibility of individuals towards HIV and

**Figure 2.** The HIV has devised different ways to evade the immune response, including a Nef-dependent mechanism that downregulates the HLA I expression, thus avoiding the recognition of the infected cells by CD8+ T lymphocytes. Selectively, Nef alters the expression of HLA-A and -B by recognition of a sequence (Y320SQAASS) present on the cyto‐ plasmic tail of these HLA molecules accelerating their endocytosis from the plasma membrane and blocking the trans‐ port of newly synthesized MHC class I molecules to the cell surface. Nef maintains the expression of HLA-C, -G, and -E unchanged, in order to inhibit the innate response of the natural killer cells (NK). NU: nucleus; GO: golgi apparatu

Association Between HLA Gene Polymorphism And The Genetic Susceptibility Of HIV Infection

http://dx.doi.org/10.5772/57538

307

Supported by grants from the State Key Development Program for Basic Research of China (No.2003CB515509 and 2009CB522401) and from National Natural Scientific Foundation of

a slower progression of AIDS.

China(No.81070450 and 30470751) to Dr. X.-Y.Z.

**Acknowledgements**

Meanwhile, under the influence of CTLs that are induced by HLA, mutation of HIV can occur. For example, TW10 peptide fragment (TAILQEQIAW) of gap protein in the HIV-1 virus, has a specific mutation on the residue 242 in the individuals with HLA-B57 or B58 and can revert to the wild type after the viruses detach from HLA-B57 or B58 molecules. This HIV mutation can cause functional loss of specific CTL, and enable HIV to adapt to the HLA environment

**Figure 2.** The HIV has devised different ways to evade the immune response, including a Nef-dependent mechanism that downregulates the HLA I expression, thus avoiding the recognition of the infected cells by CD8+ T lymphocytes. Selectively, Nef alters the expression of HLA-A and -B by recognition of a sequence (Y320SQAASS) present on the cyto‐ plasmic tail of these HLA molecules accelerating their endocytosis from the plasma membrane and blocking the trans‐ port of newly synthesized MHC class I molecules to the cell surface. Nef maintains the expression of HLA-C, -G, and -E unchanged, in order to inhibit the innate response of the natural killer cells (NK). NU: nucleus; GO: golgi apparatu

and overcome the immune responses, resulting in HIV susceptibility of specific HLA types as well as a rapid progression of AIDS. Children of mothers with AIDS who have similar HLA genes are at a higher risk of being infected with HIV, and they tend to progress to AIDS in a shorter time. The possible reason for this is that the HIV of the mother might have adapted to the HLA environment in the host, and the virus replication increases when HLA similarity is high between the mother and child, which in turn makes it is easier for HIV to propagate and lead to a faster progression of AIDS. But sometimes specific mutation of HIV can also lead to a decrease in its virulence, enabling a reduced susceptibility of individuals towards HIV and a slower progression of AIDS.

### **Acknowledgements**

chemotactic factors (CCR35 and CXCR4) are coreceptors for HIV-1. When HIV-1 infects target cells, the viruses that combine with CD4 molecules combine with coreceptors in order to enter the target cells. In high-risk populations with close contact to infected individuals but no infection, approximately one-third of the CCR5 alleles undergo deletion mutation; for instance, deletion of 32 bases of CCR5 genes (referred to as CCR5Δ32 mutation), which results in a natural immunity of the organism against HIV-1 infection at the gene level. The mutation and polymorphism changes of alleles not only influence the ability of HIV-1 to infect the target cells, but also change the onset and progression of AIDS. It is possible that HLA participates in HIV invading process through similar means, and affects AIDS progression. However, there are no validated reports on HLA's direct participation in HIV-1 infection by acting as the receptor, so far. Therefore, the susceptibility theory, which suggests that HLA acts as a receptor, needs to be subjected

**2.** HLA molecules selection pressure: The antigen-binding groove of HLA molecules combine with a specific epitope of the HIV protein (For example, gap 120), inducing the generation of helper T cells and cytotoxic T cells. In particular, CD8+ cytotoxic T lympho‐ cytes can kill infected CD4+ T lymphocyte in a direct manner, which can influence virus replication, transmission, and AIDS progression. HLA molecules can employ different epitopes for the same molecule, and stimulate generation of CTLs featuring different quantities as well as specific properties, which has been confirmed in previous studies. Therefore, this can better explain the differences in AIDS progress when individuals with

During viral infection, some viruses undergo degradation by cellular proteasome complex, and the cytosolic antigenic peptides are carried into the ER. In this organelle, the peptides are captured by HLA I molecules and then exposed on the cell surface, triggering the cytotoxic activity of the circulating CD8+ T lymphocytes, as described previously. The HIV has devised different ways to evade the immune response including a Nef-dependent mechanism that downregulates the HLA I expression, thus avoiding the recognition of the infected cells by CD8+ T lymphocytes (Fig2). Selectively, Nef alters the expression of HLA-A and -B by recognition of a sequence (Y320SQAASS) present on the cytoplasmic tail of these HLA molecules accelerating their endocytosis from the plasma membrane and blocking the transport of newly synthesized MHC class I molecules to the cell surface. Nef maintains the expression of HLA-C -G and -E unchanged, in order to inhibit the innate response of the natural killer cells (NK). Furthermore, the gp41 protein of the viral envelope upregulates the synthesis of IL-10 by monocytes; in turn, as mentioned before, this cytokine increases the expression of

Meanwhile, under the influence of CTLs that are induced by HLA, mutation of HIV can occur. For example, TW10 peptide fragment (TAILQEQIAW) of gap protein in the HIV-1 virus, has a specific mutation on the residue 242 in the individuals with HLA-B57 or B58 and can revert to the wild type after the viruses detach from HLA-B57 or B58 molecules. This HIV mutation can cause functional loss of specific CTL, and enable HIV to adapt to the HLA environment

to further scientific scrutiny.

306 HLA and Associated Important Diseases

certain HLA phenotypes infected with HIV.

HLA-G molecules to control immune response and facilitate infection.

Supported by grants from the State Key Development Program for Basic Research of China (No.2003CB515509 and 2009CB522401) and from National Natural Scientific Foundation of China(No.81070450 and 30470751) to Dr. X.-Y.Z.

### **Author details**

Fang Yuan and Yongzhi Xi\*

\*Address all correspondence to: xiyz@yahoo.com

Department of Immunology and National Center for Biomedicine Analysis, Beijing Hospital Affiliated to Academy of Medical Sciences, Beijing, PRC

resistance to human immunodeficiency virus type 1 infection. J Infect Dis, 2003, 187:

Association Between HLA Gene Polymorphism And The Genetic Susceptibility Of HIV Infection

http://dx.doi.org/10.5772/57538

309

[11] Al Jabri AA. HLA and in vitro susceptibility to HIV infection. Mol Immunol, 2002,

[12] Liu H, Hwangbo Y, Hotle S, et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly ex‐

[13] Jansen CA, Kostense S, Vandenberghe K, et al. High responsiveness of HLA-B57-re‐ stricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of

[14] Walker BD, Korber BT. Immune control of HIV: the obstacles of HLA and viral diver‐

[15] Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and re‐

[16] Kuhn L, Abrams EJ, Palumbo P, et al. Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease pro‐

[17] Grifoni A, Montesano C, Palma P. et al. Role of HLA-B α-3 domain amino acid posi‐

[18] Matthews PC, Listgarten J, Carlson JM, et al. Co-operative additive effects between

[19] Kloverpris HN, Stryhn A, Harndahl M, et al. HLA-A\*68:02-restricted Gag-specific cy‐ totoxic T lymphocyte responses can drive selection pressure on HIV but are subdo‐

[20] Vaidya SA, Streeck H, Beckwith N, et al. Temporal effect of HLA-B\*57 on viral con‐

[21] Lecuroux C, Saez A, Girault I, et al. Both HLA-B\*57 and plasma HIV RNA levels con‐ tribute to the HIV-specific CD8+ T cell response in HIV controllers. J Virol. 2013. [22] Yager N, Robinson N, Brown H, et al. Longitudinal analysis of an HLA-B\*51-restrict‐ ed epitope in integrase reveals immune escape in early HIV-1 infection. AIDS. 2013,

[23] Ranasinghe S, Cutler S, Davis I, et al. Association of HLA-DRB1-restricted CD4 T cell

tion 194 in HIV disease progression. Mol Immunol. 2013, 53(4):410-3.

trol during primary HIV-1 infection. Retrovirology. 2013, 10(1):139.

responses with HIV immune control. Nat Med. 2013, 19(7):930-3.

HLA alleles in control of HIV-1. PLoS One. 2012, 7(10):e47799.

minant and ineffective. AIDS. 2013, 27(11):1717-23.

posed to HIV-1. J Infect Dis, 2004, 190: 1055-1058.

sity. Nat Immunol, 2001, 2: 437-475.

gression. AIDS, 2004, 18: 1281-1289.

HLA-B57 in HIV-infection. Eur J Immunol, 2005, 35: 150-158.

version after transmission. Nat Med, 2004, 10: 282-289.

1404-1410.

38: 959-967.

27(3):313-23.

### **References**


resistance to human immunodeficiency virus type 1 infection. J Infect Dis, 2003, 187: 1404-1410.

[11] Al Jabri AA. HLA and in vitro susceptibility to HIV infection. Mol Immunol, 2002, 38: 959-967.

**Author details**

**References**

Fang Yuan and Yongzhi Xi\*

308 HLA and Associated Important Diseases

\*Address all correspondence to: xiyz@yahoo.com

Affiliated to Academy of Medical Sciences, Beijing, PRC

infection. J Infect Dis, 1999, 180: 526-529.

omed Environ Sci, 2004, 17: 203-208.

men. J Infect Dis, 2003, 188: 856-863.

Res Hum Retroviruses, 2004, 20: 692-697.

2001, 79: 151-157.

deficiency virus type 1. J Virol, 2002, 76: 8276-8284.

Department of Immunology and National Center for Biomedicine Analysis, Beijing Hospital

[1] Grimwood J. Schmutz J. Genomics: six is seventh. Nature, 2003, 425:775-776.

[2] Lefrere JJ, Mariotti M, Morand-Joubert L, et al. Plasma human immunodeficiency vi‐ rus RNA below 40 Copies/ml is rare in untreated persons even in the first years of

[3] Tang J, Tang S, Lobashevsky E, et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immuno‐

[4] Xu MY, Hong KX, Deng XL , et al. Association of HLA-B alleles with human immu‐ nodeficiency virus type 1 infection in the Yi ethnic group in Sichuan province. Bi‐

[5] MacDonald KS, Matukas L, Embree JE, et al. Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett,

[6] Roe DL, Lewis RE, Cruse JM. Association of HLA-DQ and -DR alleles with protec‐

[7] Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advant‐

[8] Dorak MT, Tang J, Tang S, et al. Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white

[9] Farquhar C, Rowland-Jones S, Mbori-Ngacha D, et al. Human leukocyte antigen (HLA) B\*18 and protection against mother-to-child HIV type 1 transmission. AIDS

[10] Liu C, Carrington M, Kaslow RA, et al. Association of polymorphisms in human leu‐ kocyte antigen class I and transporter associated with antigen processing genes with

tion from or infection with HIV-1. Exp Mol Pathol, 2000, 68: 21-28.

age and B\*35-Cw\*04 disadvantage. Science, 1999, 283: 1748-1752.


[24] Levitz L, Koita OA, Sangare K, et al. Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine. Vaccine. 2012, 30(52):7547-60.

**Chapter 12**

**Association Between HLA Gene Polymorphism and the**

Theoretically, any infectious disease with an infection source, transmission route, and susceptible population is able to infect any population. However, studies of human develop‐ ment history, especially those of infectious disease history, have clearly shown that ethnic and regional differences in susceptibility to some infectious diseases actually exist, even if their infection sources and transmission routes are the same. In terms of the 40 types of new infectious diseases that have occurred worldwide in the past 40 years, the epidemiology of some infectious diseases (including severe acute respiratory syndrome (SARS)) has been dominated by regional/territorial or ethnic oriented infections. Examples, along with the year of first occurrence, include:Ebola hemorrhagic fever caused by Ebola virus (1977), Legion‐ naires' disease caused by *Legionella pneumophila* (1977), hemorrhagic fever with renal syndrome caused by hantavirus (1977), T cell lymphoma leukemia caused by human T-lymphotropic virus type I (1980), hemorrhagic colitis caused by E. coli O157:H7 (1982), hairy cell leukemia caused by human T-lymphotropic virus type II (1982), and the British BSE (bovine spongiform encephalopathy) that created worldwide shock. Along with the effects of infection sources and transmission routes, the contributions of racial or genetic factors to these regional/territorial diseases are still under discussion. Clearly, these infectious diseases occurred more frequently and with greater severity in certain regions and ethnicities. The SARS outbreak in 2002-2003 spread mainly in Asia, especially in China; the most susceptible populations were mainland and overseas Chinese. These observations lead us to consider the important theoretical and practical topic of the relationship between SARS genetic predisposition and individual clinical onset. However, the sudden disappearance of SARS also left us with many revelations.

> © 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**Genetic Susceptibility of SARS Infection**

Additional information is available at the end of the chapter

Yuying Sun and Yongzhi Xi

http://dx.doi.org/10.5772/57561

**1. Introduction**

